List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 26 studies with search of: "Antipsychotic Agents" | India
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Sarizotan in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
Condition: Neuroleptic-Induced Tardive Dyskinesia
Intervention: Drug: Sarizotan
2 Recruiting Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
Conditions: Psychotic Disorders;   Schizophrenic Disorders;   Schizophrenia;   Dementia Praecox.
Intervention: Drug: Paliperidone ER
3 Active, not recruiting Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease
Conditions: Parkinson Disease;   Psychotic Disorders
Interventions: Drug: melperone HCl;   Drug: Placebo
4 Completed A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Bacopa monnieri;   Drug: Nardostachys jatamansi;   Drug: Olanzapine
5 Recruiting A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients.
Condition: Schizophrenia
Interventions: Drug: Paliperidone ER;   Drug: Paliperidone ER;   Drug: Placebo;   Drug: Paliperidone ER
6 Completed A 4-Week Study of Mifepristone in the Prevention of Risperidone-Induced Weight Gain in Healthy Male Volunteers
Condition: Healthy
Interventions: Drug: risperidone plus mifepristone;   Drug: risperidone plus placebo;   Drug: risperidone-matched placebo plus mifepristone
7 Recruiting Comparison of Paliperidone Palmitate and Risperdal Consta in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Paliperidone Palmitate;   Drug: RISPERDAL CONSTA
8 Recruiting Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Placebo;   Drug: RGH-188;   Drug: RGH-188;   Drug: RGH-188;   Drug: Risperidone
9 Completed Dose-Response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia
Condition: Schizophrenia
Interventions: Drug: PF-00217830;   Other: Placebo;   Drug: Aripiprazole;   Drug: PF-00217830;   Drug: PF-00217830
10 Active, not recruiting A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
Condition: Bipolar Disorder
Interventions: Drug: Lithium or Valproate with PBO;   Drug: Lithium or Valproate with Aripiprazole
11 Completed Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
Conditions: Bipolar Disorder;   Depression, Bipolar
Interventions: Drug: Ziprasidone;   Drug: Placebo
12 Completed Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
Conditions: Bipolar Mania;   Bipolar Disorder
Interventions: Drug: Placebo;   Drug: Ziprasidone Oral Capsule
13 Completed SB-773812 Administered In Adults With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SB-773812;   Drug: Olanzapine
14 Terminated A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
Condition: Bipolar Disorder
Interventions: Drug: Aripiprazole;   Drug: Placebo
15 Recruiting Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Ziprasidone oral capsules
16 Completed Quetiapine Fumarate Bipolar Maintenance Monotherapy
Condition: Bipolar Disorder
Intervention: Drug: quetiapine fumarate
17 Recruiting Safety and Efficacy of Ziprasidone in Adolescents With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: placebo;   Drug: Ziprasidone oral capsules
18 Completed SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia
Condition: Schizophrenic Disorder
Interventions: Drug: Seroquel Sustained Release (SR);   Drug: Seroquel Immediate Release (IR);   Drug: Placebo
19 Completed Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Casopitant (GW679769) oral tablets;   Drug: Casopitant (GW679769) intravenous;   Drug: Dexamethasone intravenous;   Drug: Ondansetron oral tablets
20 Completed Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: quetiapine fumarate tablets

Previous Page Studies Shown (1-20) Next Page (21-26)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services